stockrow
Saturday 7 November 2026
Export DHC’s income statement to Excel — free account
Diversified Healthcare Trust
DHC Real Estate Reit Healthcare Facilities
Diversified Healthcare Trust’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, up 2.84% from fiscal 2024.
- Revenue
- −5.41%
- EPS
- +69.4%
- Free cash flow
- +100.7%
- Total debt
- −11.7%
Quarter to September 2026, against a year earlier
7.02
0.01
−0.14%
Follow DHC
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
1.28 | 1.49 | 1.05 | 0.76 | |
P/FCF ratio |
10.38 | 20.88 | 3.64 | 2.76 | |
P/Operating CF |
69.06 | 58.33 | 191.58 | (57.95) | |
P/B ratio |
1.24 | 1.41 | 0.99 | 0.70 | |
Price to Tangible BV |
1.24 | 1.41 | 0.99 | 0.70 | |
EV/Sales |
3.12 | 3.30 | 2.84 | 2.53 | |
EV/EBITDA |
19.62 | 30.79 | 29.85 | 28.85 | |
EV/Operating CF |
85.45 | (218.59) | (536.52) | (198.51) | |
EV/FCF |
25.31 | 46.21 | 9.82 | 9.21 | |
Quick Ratio |
5.32 | 4.67 | 5.36 | 4.10 | |
Current Ratio |
5.32 | 4.67 | 5.36 | 3.97 | |
Net Debt/EBITDA |
44.93 | 35.22 | 37.36 | 38.13 | |
Debt/Assets |
57.38% | 56.69% | 56.28% | 55.05% | |
Debt/Equity |
1.57 | 1.52 | 1.48 | 1.44 | |
Asset Turnover |
0.33 | 0.33 | 0.33 | 0.32 | |
Operating CF/Net income |
(0.55) | (1.03) | (0.19) | 0.95 | |
Capex/Depreciation |
(0.41) | (0.26) | (0.54) | 2.81 | |
Interest Coverage |
(0.39) | (0.01) | (0.13) | (0.30) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
3.98% | 5.29% | 3.83% | 3.30% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
(1.34) | (1.13) | (1.57) | (2.21) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(8.13%) | (11.94%) | (20.03%) | (24.54%) | |
Free Cash Flow Yield |
9.64% | 4.79% | 27.46% | 36.28% | |
Revenue per Share |
1.53 | 1.52 | 1.52 | 1.58 | |
Operating CF per Share |
0.11 | 0.16 | 0.03 | (0.08) | |
Capex per Share |
(0.11) | (0.07) | (0.15) | 0.86 | |
Free Cash Flow per Share |
0.00 | 0.09 | (0.11) | 0.78 | |
Cash per Share |
0.54 | 0.57 | 0.58 | 0.51 | |
Shareholders Equity per Share |
6.35 | 6.57 | 6.73 | 6.93 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
6.35 | 6.57 | 6.73 | 6.93 | |
Free Cash Flow |
0.52 | 21.33 | (26.82) | 187.31 | |
Working Capital |
106.32 | 107.00 | 113.77 | 91.12 | |
Capital Expenditures |
(26.87) | (17.06) | (35.17) | 207.42 | |
Net Current Asset Value |
(2,528.58) | (2,519.67) | (2,507.28) | (2,573.88) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.07 | 0.05 | 0.10 | (0.55) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
— | — | — | 2.98 | |
Average Payables |
— | — | — | 15.48 | |
Average Assets |
4,436.69 | 4,497.57 | 4,631.70 | 4,749.13 | |
Average Common Equity |
1,609.31 | 1,718.90 | 1,784.24 | 1,812.21 |
Columns are period end dates · fundamentals updated 5 Nov 2026